Select Medical Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 01 2026
0mins
Source: seekingalpha
- Acquisition Agreement: Select Medical announced an acquisition agreement led by Robert Ortenzio, with shareholders set to receive $16.50 per share in cash, expected to close in mid-2026, which will provide the company with an additional $1 billion in loan capacity, enhancing financial flexibility.
- Revenue Growth: The company reported a 5% year-over-year revenue increase, with inpatient rehabilitation revenue rising over 14% to approximately $351.9 million, indicating positive outcomes from its business expansion strategy amid strong market demand.
- Financial Performance Analysis: Despite a 6.5% decline in adjusted EBITDA to $141.6 million, management maintained its full-year 2026 revenue guidance between $5.6 billion and $5.8 billion, reflecting confidence in future performance.
- Market Risk Concerns: Management highlighted an increase in denial rates in the Medicare Advantage space, which is expected to negatively impact revenue in critical illness recovery hospitals by approximately $13 million to $14 million, reflecting regulatory and market challenges within the industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEM
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.510
Low
17.00
Averages
18.75
High
21.00
Current: 16.510
Low
17.00
Averages
18.75
High
21.00
About SEM
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.
See More
Kaskela Law Investigates Select Medical Buyout Proposal
- Acquisition Price Controversy: Select Medical Holdings Corp. announced a buyout at $16.50 per share, while analysts maintained a price target of $19.00, indicating the buyout price may undervalue the shares, potentially impacting shareholder returns.
- Legal Investigation Initiated: Kaskela Law is investigating whether the transaction is fair and provides sufficient value to shareholders, and if company executives breached fiduciary duties, which could lead to legal repercussions and affect the company's reputation.
- Shareholder Rights Protection: Select Medical shareholders are encouraged to contact Kaskela Law for additional compensation and legal support, highlighting the importance of shareholder rights and potentially prompting more legal actions from affected investors.
- Investor Compensation Potential: Kaskela Law has recovered over $500 million for investors since 2020, showcasing its successful track record in securities fraud and M&A litigation, which may attract more affected shareholders to participate in the investigation.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating companies such as KORE Group Holdings, Inc., Select Medical Holdings Corporation, and TopBuild Corp. for potential violations of federal securities laws or breaches of fiduciary duties, which may impact shareholder rights.
- KORE Transaction Details: KORE Group Holdings, Inc. is being sold to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, with terms that may limit superior competing offers, affecting shareholder options.
- Select Medical Sale: Select Medical Holdings Corporation is being sold for $16.50 per share to a consortium led by company executives and directors, and Halper Sadeh LLC may seek increased compensation for shareholders.
- TopBuild Shareholder Options: TopBuild Corp. shareholders can choose to sell their shares for $505.00 in cash or 20.2 shares of QXO common stock, with Halper Sadeh LLC representing shareholders to seek additional disclosures and rights protection.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Insider Trading Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by its executives and directors for $16.50 per share in cash, which may infringe on shareholder rights.
- UniFirst Acquisition Details: UniFirst Corporation is being sold to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, potentially limiting superior competing offers.
- Centessa Pharmaceuticals Deal: Centessa Pharmaceuticals plc is selling to Eli Lilly for $38.00 in cash per share plus a non-transferable contingent value right that could yield up to $9.00 upon achieving certain milestones, prompting shareholders to consider their rights.
- Assertio Sale Dynamics: Assertio Holdings, Inc. is being sold to Garda Therapeutics for $18.00 per share in cash along with a contingent value right, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
See More
Russell 2000 Index Potential Stock Analysis
- Select Medical Risks: Select Medical (SEM), with a market cap of $2.04 billion, has seen declining admissions over the past two years, struggling to increase sales volumes and relying on price hikes, raising investor concerns about its future profitability.
- Azenta's Poor Performance: Azenta (AZTA), valued at $808 million, has experienced a 1.6% annual sales decline over the past two years, with earnings per share contracting by 24.8% annually over five years, indicating its products have struggled to connect with the market, casting doubt on its long-term viability.
- Talos Energy Investment Opportunity: Talos Energy (TALO), with a market cap of $2.56 billion, boasts a 16.9% annual revenue growth over the last eight years, indicating market share gains, while its 72.4% gross margin and strong free cash flow provide flexibility for growth investments or shareholder returns.
- Market Environment Analysis: The high-risk, high-reward nature of the Russell 2000 index makes stock selection critical, and while there are potential quality stocks, investors must carefully assess the financial resilience and market adaptability of smaller companies.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.
See More
Kaskela Law Investigates Select Medical Buyout Proposal
- Acquisition Price Controversy: Select Medical Holdings Corp. announced a buyout at $16.50 per share, while analysts maintained a price target of $19.00, indicating the buyout price may undervalue the shares, potentially impacting shareholder returns.
- Legal Investigation Initiated: Kaskela Law is investigating whether the transaction is fair and provides sufficient value to shareholders, and if company executives breached fiduciary duties, which could lead to legal repercussions and affect the company's reputation.
- Shareholder Rights Protection: Select Medical shareholders are encouraged to contact Kaskela Law for additional compensation and legal support, highlighting the importance of shareholder rights and potentially prompting more legal actions from affected investors.
- Investor Compensation Potential: Kaskela Law has recovered over $500 million for investors since 2020, showcasing its successful track record in securities fraud and M&A litigation, which may attract more affected shareholders to participate in the investigation.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating companies such as KORE Group Holdings, Inc., Select Medical Holdings Corporation, and TopBuild Corp. for potential violations of federal securities laws or breaches of fiduciary duties, which may impact shareholder rights.
- KORE Transaction Details: KORE Group Holdings, Inc. is being sold to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, with terms that may limit superior competing offers, affecting shareholder options.
- Select Medical Sale: Select Medical Holdings Corporation is being sold for $16.50 per share to a consortium led by company executives and directors, and Halper Sadeh LLC may seek increased compensation for shareholders.
- TopBuild Shareholder Options: TopBuild Corp. shareholders can choose to sell their shares for $505.00 in cash or 20.2 shares of QXO common stock, with Halper Sadeh LLC representing shareholders to seek additional disclosures and rights protection.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Insider Trading Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by its executives and directors for $16.50 per share in cash, which may infringe on shareholder rights.
- UniFirst Acquisition Details: UniFirst Corporation is being sold to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, potentially limiting superior competing offers.
- Centessa Pharmaceuticals Deal: Centessa Pharmaceuticals plc is selling to Eli Lilly for $38.00 in cash per share plus a non-transferable contingent value right that could yield up to $9.00 upon achieving certain milestones, prompting shareholders to consider their rights.
- Assertio Sale Dynamics: Assertio Holdings, Inc. is being sold to Garda Therapeutics for $18.00 per share in cash along with a contingent value right, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
See More
Russell 2000 Index Potential Stock Analysis
- Select Medical Risks: Select Medical (SEM), with a market cap of $2.04 billion, has seen declining admissions over the past two years, struggling to increase sales volumes and relying on price hikes, raising investor concerns about its future profitability.
- Azenta's Poor Performance: Azenta (AZTA), valued at $808 million, has experienced a 1.6% annual sales decline over the past two years, with earnings per share contracting by 24.8% annually over five years, indicating its products have struggled to connect with the market, casting doubt on its long-term viability.
- Talos Energy Investment Opportunity: Talos Energy (TALO), with a market cap of $2.56 billion, boasts a 16.9% annual revenue growth over the last eight years, indicating market share gains, while its 72.4% gross margin and strong free cash flow provide flexibility for growth investments or shareholder returns.
- Market Environment Analysis: The high-risk, high-reward nature of the Russell 2000 index makes stock selection critical, and while there are potential quality stocks, investors must carefully assess the financial resilience and market adaptability of smaller companies.
See More
